CKAP2LP1

Across TCGA pan-cancer cohorts, CKAP2LP1 RNA is linked to patient survival in 13 of 34 cancer types, making it the most broadly survival-associated CKAP2LP1 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher CKAP2LP1 RNA is associated with worse disease-free survival. In most high-consensus cancer types, elevated CKAP2LP1 expression acts as an unfavorable survival marker, although some lineages such as ESCA and UCS show a favorable association.

LUAD, DLBC, and THCA are the cancer types where CKAP2LP1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	DFS	Tertile	IV	0.047	0.565	<.001	51	view →
DLBC	OS	Quartile	III,IV	0.239	1.000	.005	43	view →
THCA	OS	Tertile	III,IV	0.705	0.896	.001	39	view →
COAD	OS	Tertile	IV	0.136	0.666	.001	36	view →
ESCA	OS	Median	IV	0.698	0.222	.006	18	view →
UCS	DFS	Tertile	III,IV	0.575	0.181	.046	12	view →
READ	OS	Tertile	II,III,IV	0.718	0.943	.029	12	view →
PAAD	DFS	Tertile	III,IV	0.152	0.821	.045	9	view →
CHOL	DFS	Tertile	III,IV	0.118	0.476	.031	9	view →
PCPG	DFS	Tertile	All	0.638	0.840	.017	9	view →
KIRP	OS	Quartile	II,III,IV	0.319	0.783	.012	7	view →
MESO	OS	Quartile	III,IV	0.044	0.665	.001	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 13 lineages.

CKAP2LP1–LUAD (DFS)

Open the LUAD breakdown →